Home
About Us
Management
Technology & Products
Electroceuticals®
EFFECT Trial
SofPulse® Electroceutical® Therapy
Scientific Studies
Patents
Investors
Overview
Regulation A Offering
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
Contact
Home
About Us
Management
Technology & Products
Electroceuticals®
EFFECT Trial
SofPulse® Electroceutical® Therapy
Scientific Studies
Patents
Investors
Overview
Regulation A Offering
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
Contact
Management
Kodenbushi
Investors
Overview
Regulation A Offering
Regulation A Offering
News / Events
Press Releases
Email Alerts
Company Information
Profile
Management Team
Scientific Advisory Board
Presentations
IR Contacts
FAQ
Video
Financial Information
Quarterly Results
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Board of Directors
Email Alerts
Presentations
Tear Sheet
IR Contacts
RSS News Feed
Press Releases
All News
By Year:
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Jun 1, 2020 • 10:00 AM EDT
Endonovo Therapeutics Announces International Expansion with Distribution Agreement for SofPulse® in Taiwan, Republic of China
May 26, 2020 • 8:18 AM EDT
Endonovo Therapeutics Enters into $10 million Equity Line Agreement with Cavalry Fund
May 4, 2020 • 8:15 AM EDT
Endonovo Therapeutics Announces Positive 2019 Fiscal Results
Apr 16, 2020 • 8:00 AM EDT
Endonovo Therapeutics Announces Eight Additional Hospitals Approved Use of SofPulse® at Their Facilities
Mar 25, 2020 • 8:00 AM EDT
Endonovo Therapeutics seeks Intensive Care Unit Partners for Investigational Adjunctive Treatment for Severe Respiratory Inflammatory Complications for COVID-19 Patients.
Mar 16, 2020 • 8:00 AM EDT
Endonovo to Donate SofPulse® Units for Investigational Use to Evaluate Inhibition of Inflammatory Symptoms Associated with COVID-19
Mar 2, 2020 • 7:30 AM EST
Endonovo Therapeutics Files 8K With SEC Regarding SofPulse®
Feb 24, 2020 • 1:00 PM EST
Endonovo Therapeutics Introduces Support of SofPulse® With A New Ancillary Multi-Use Patient Brace From Protex
Feb 20, 2020 • 11:00 AM EST
Endonovo Therapeutics Begins Process For Medical Reimbursements
Feb 13, 2020 • 7:30 AM EST
Endonovo Therapeutics Announces collaborating with a Stanford University sponsored Orthopedic Shoulder and Knee Study
<< Previous
1
2
3
4
5
6
7
8
9
10
...16
Next >>
Show All